Rates of antibiotic use in newborns vary 27-fold between California hospitals without a medical reason for the large differences, a new study found.
Using neuroimaging and machine learning, researchers were able to predict whether antidepressants would help individual patients.
This is the first in a series of three blog posts on aspirin for prevention. It clarifies the potential benefits and harms of aspirin use.
Using drug-designing software, Stanford researchers found a new anesthetic that appears to work while maintaining blood pressure.
Through the Humanwide project, a patient's pharmacogenomic evaluation helped doctors prescribe a pain reliever that is effective for her individual biology.
In a recent commentary, Alan Schatzberg speaks out about the potential harms, and many questions, that surround ketamine's use to treat depression.
At a recent Dean's Lecture Series, Dean Lloyd Minor discussed organizational culture and diversity with Emma Walmsley, CEO of GlaxoSmithKline.
Results from a multi-center clinical trial show that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.
Stanford researchers make progress in predicting which patients will suffer heart problems from chemotherapy, and may have found a drug to mitigate them.
Retail prices at pharmacies may bear little relationship to the actual market prices of medications, and pharmacy benefit managers are part of the reason.
More than a third of patients who are prescribed statins fail to take them regularly, and they are dying at higher rates as a result.
Scientists have created an algorithm that works to generate and refine DNA sequences that are likely to code for antimicrobial proteins.
Patients who are taking the most common type of antidepressant may feel more pain when taking certain opioids, Stanford researchers have found.
Patients who undergo physical therapy soon after a pain diagnosis are less likely to use opioids in the long term, a Stanford-Duke study finds.
The U.S. Preventative Services Task Force encourages those who are at high risk of contracting HIV to take a daily pre-exposure drug.
Access and cost of insulin is affecting those who need it most, and without major improvements, millions will be without a treatment, a new study suggests.